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Reliable cause-specific mortality data constitute a crucial resource for health monitoring, service planning
and prioritisation. However, in the majority of the world’s poorest settings, systematic health and vital event
surveillance systems are weak or non-existent. As such, deaths are not counted and causes of death remain
unregistered for more than two-thirds of the world’s population.
For researchers, health workers and policy makers in resource-poor settings, therefore, attempts to measure
mortality have to be implemented from first principles. As a result, there is wide variation in mortality
surveillance methodologies in different settings, and lack of standardisation and rigorous validation of these
methods hinder meaningful comparison of mortality data between settings and over time.
With a particular focus on Health and Demographic Surveillance Systems (HDSSs), this paper summarises
recent research and conceptual development of certain methodological aspects of mortality surveillance
stemming from a series of empirical investigations. The paper describes the advantages and limitations of
various methods in particular contexts, and argues that there is no single methodology to satisfy all data
needs. Rather, methodological decisions about mortality measurement should be a synthesis of all available
knowledge relating to clearly defined concepts of why data are being collected, how they can be used and
when they are of good enough quality to inform public health action.
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The data we want
M
ortality registration is the oldest form of
disease surveillance, and its importance for
epidemiology and public health planning is
perhaps obvious. Two of the Millennium Development
Goals and one out of three essential elements of the
Human Development Index are specific mortality mea-
sures (1, 2), enhancing the need for valid and representa-
tive data on mortality and its risk factors to track progress,
evaluate disease-control programmes and monitor major
global health initiatives. Consistent and reliable cause-
specific mortality data therefore constitute a crucial and
major resource for health planning and prioritisation (3).
However, the chance of a death being registered and
the cause of death documented strongly depends on the
socioeconomic status of the community and nation in
which it occurs (3). With little or no progress in civil
registration systems in the last 50 years, between
two-thirds and three-quarters of the world’s population
remain outside any kind of systematic health surveillance
(48). As of 2003, 60% of United Nations member states
have supplied cause-of-death data to the WHO. However,
regional coverage of death registration is less than 10% in
the Africa region and is considered to be complete in only
one-third of the 115 reporting countries  those providing
data of ‘high’ quality representing only 12% of the
world’s population (6, 9). This ongoing lack of knowledge
on who lives and dies where and from what has been
described as ‘the single most critical failure of develop-
ment over the past 30 years’ and the lack of any record of
the lives of billions living in poorer countries as a ‘scandal
of invisibility’ (10). Tracing the imprint of a person’s
existence, including their birth and death, not only
confirms ideals of citizenship, but also represents the
first step in securing population rights to life, freedom
and protection (11).
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A popular application of Finagel’s law to health
measurement states that ‘the data we have are not the
data we need; the data we need are not the data we want;
the data we want are unobtainable’ (12). Underlying this
saying are the methodological realities of data capture as
well as the conceptual aspects of the intended users and
use of data (Fig. 1). In theory, mortality measurement is
based on highly interconnected relationships between the
actual situation one wants to measure, the methods
available for measurement and data needs, which should
be informed by the intended use of the data. In practice,
methodological approaches to measuring mortality and
assigning causes of death do not always appear to be
directly informed by the intended use of the data, but
rather by an underlying presumption of a ‘one-size-fits-
all’ nature and utility of mortality data.
The data we need
In practical public health terms, there are different levels
at which cause-specific mortality data are needed, ran-
ging from the local to the global. Health managers
require cause-specific mortality data to effectively plan
health services based on local patterns of disease. At this
level, it is essential to be able to monitor major causes of
death simply and cheaply. The breakdown of cause-of-
death categories based on a few hundred cases is needed
and very detailed causes of death would be superfluous.
Epidemiologists, health service researchers and assessors
of specific health interventions, such as safe motherhood
interventions, need a consistent assessment of cause-
specific mortality to determine trends in causes of death
that enable evaluations of the effectiveness of interven-
tions across time and regions. For such users, a reduction
in rates of a specific cause of death is usually an
important endpoint  for example, detailed sub-causes
of maternal mortality. National and global authorities
concerned with building respective pictures of health
patterns require consistent and reliable cause-specific
mortality data from a wide range of settings (3). For all
users in low- and some middle-income settings, however,
mortality registration processes and methods often have
to be implemented from first principles. This has resulted
in a variety of different approaches to population health
surveillance, ranging from one-off cross-sectional surveys
to longitudinal monitoring of population cohorts. As a
result, mortality surveillance methodologies vary widely
between settings and seemingly ad hoc approaches that
are not always explicit about the gap in health informa-
tion that they are attempting to fill or do not seem to be
directly related to the intended use of the data are
apparent. Furthermore, lack of standardisation and
rigorous validations hinder meaningful comparisons of
data between settings and over time, and may diminish
the use of surveillance data for public health action.
A common, if perhaps simplistic, understanding of the
purpose of population surveillance is to gain an overall
impression of population composition and distribution of
risk factors to inform public health action. If this is the
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Fig. 1. Conceptual framework of mortality surveillance. The methods we use determine the data we get. Appreciation of
differing needs and uses of mortality data should inform the methods used so that the data we have are reconciled with the data
we need.
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case, then when are surrogate methods for more wide-
spread health surveillance in resource-poor settings and
the data derived from these methods ‘good enough’ for
this purpose? Understanding the particular strengths and
limitations of existing methods, the data that they
generate and how such data can be used to meet specific
needs is essential to reconcile the data we want with the
data we actually need and the data that we can get. With
a particular focus on Health and Demographic Surveil-
lance Systems (HDSSs), this paper summarises recent
research and conceptual development on some metho-
dological aspects of mortality surveillance that stem from
a series of empirical investigations (13).
The data we have
For the majority of the world’s population, for whom
vital events of births and deaths are not counted, HDSSs
have emerged as a useful surrogate. Notwithstanding
local and contextual variations, HDSSs maintain regular
surveillance of births, deaths and migrations and, fre-
quently, social and economic correlates of population
and health dynamics, in an open cohort population
within a clearly circumscribed geographic area (14).
This is achieved through selecting a population, conduct-
ing an initial census and following up by periodic
household surveys. Such approaches are unique in that
they are able to generate data in settings with no other
comparable source of information on births, deaths and
causes of death, and vast amounts of high quality
research, training and service provision are generated
from such sites, much of which would be difficult to do
without such infrastructures (15). Nevertheless, metho-
dological variation between sites and the fact that HDSSs
are localised systems that cover only a small proportion
of total national populations has somewhat limited the
wider utility of HDSS data by national and international
researchers and practitioners.
In the context of HDSSs, it has been suggested that the
resource-intensive active follow-up of individuals can
only be justified if the results can be extrapolated
meaningfully into the surrounding 100-fold population
(5, 16). In focus here are issues of representativity and
generalisability. ‘Representativity’ refers to the context of
a site and the extent to which physical, cultural, religious
and social characteristics approximate to other areas.
‘Generalisability’ relates to the extent to which findings
from an investigation using particular methods in a
particular setting (i.e. an HDSS) can plausibly be applied
more widely (17). However, there remain no ‘best-
practice’ guidelines for enhancing representativity or
generalisability and the size and selection of HDSS
populations are seemingly influenced more by economic
restraints than sound sampling theory. Such determining
factors have been criticised for failing to take into
account the number of deaths needed to yield sufficiently
robust information on cause-specific mortality (8). While
mathematical formulae are available to calculate neces-
sary sample sizes for acceptable degrees of precision (18
20), including methods for determining efficient sizes for
sample-based mortality surveillance systems in situations
where prior information on the cause composition of
mortality is lacking (8, 21), there is no evidence that these
are used in existing HDSSs. Given that budgets, geogra-
phy and national contexts vary widely, there is unlikely to
be a simple, one-size-fits-all solution to determining the
ideal population surveillance size, but choice should be
related to specific goals and intended use of the data, with
appreciation for the impact on representativity and
generalisability.
Thorough understanding of causal pathways and
potential intervention strategies in relation to mortality
requires the reliable measurement of basic population
parameters such as age, gender and socioeconomic
distributions, which are likely to have a wide distribution
among any population. The distributions of such para-
meters should have important implications on the choice
of sampling method, yet this is not apparent in current
HDSS methods and a wide variety of sampling proce-
dures are utilised, not least with regards to their complex-
ity (19, 2224). Given the reality of variation in sampling
approaches between sites, it is prudent to know a priori
whether and to what extent this might hinder cross-site
comparisons of data. Such questions are not only
important for the establishment of the HDSSs them-
selves, but also for one-off surveys in resource-poor
settings and nested surveys within HDSS settings.
Empirical investigations into sampling approaches
for population surveillance emphasises the need to
consider general population distributions and uniformity
of certain parameters within localities when selecting
sampling methods (16, 25). While 1% samples drawn
from reference datasets using different sampling ap-
proaches can represent the reference data well, distribu-
tion of parameters has been shown to be an important
consideration. For example, consistent and approxi-
mately normal distribution of gender means that the
proportion of males in a population can be well
represented irrespective of the sampling approach. In
contrast, parameters with more skewed and inconsistent
distributions, such as education, are more difficult to
capture. Modelling of multistage HDSS-style sampling
approaches appear to perform inconsistently with regard
to reliability and representativity of various demographic
and health parameters, emphasising the need to consider
general population distributions and uniformity of cer-
tain parameters within localities when selecting methods.
As with sample size, there is unlikely to be a simple, ‘one-
size-fits-all’ sampling technique that can satisfy all needs
Dying to count: mortality surveillance in resource-poor settings
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of survey design, therefore compromises, which are
informed by empirical evidence, are necessary.
In terms of the generalisability of HDSS data to wider
national populations, empirical comparisons with Demo-
graphic and Health Survey$ (DHS) data have shown that
population composition and certain mortality risk fac-
tors identified in HDSSs are broadly applicable to
regional and national populations (2628). It appears
from these investigations that HDSSs have more scope to
detect the extent of local variations in population
composition and health status than DHS methods, which
average out local variations across regions or nations. As
was the case for the sampling technique, general popula-
tion distributions and uniformity of certain parameters
within localities are important determinants of whether
locally derived estimates can be applied nationally, and
vice versa. The differing yet complementary character-
istics of DHS and HDSS mean that, when combined,
these two data sources have the potential to characterise
national population composition and health status as
well as the extent of local variation  both of which are
important for health monitoring and planning. Moving
on from discontinuous thinking about data sources
and continually drawing comparisons, there is room for
further investigations into how data from different
sources, such as HDSSs and DHSs, could be combined
to provide more complete pictures of population health
and maximise the potential utility of existing data in
supporting developing-country health systems (2629).
Data quality
Regardless of specific methods used, a certain amount of
error is to be expected in population surveillance (30, 31),
and the extent to which imprecision should affect the use
of mortality surveillance data is an important concept
with practical implications. A significant proportion of
population surveillance operations and resources are
dedicated to data quality-assurance mechanisms (32).
The majority of member sites of the INDEPTH% net-
work, for example, describe scheduled random re-visits of
primary sampling units as a method of data quality
control, with the percentage of households re-visited
ranging from 2% (Agincourt HDSS, South Africa) to
between 5 and 10% (Nouna HDSS, Burkina Faso) (14,
33). Recent developments in direct data capture using
handheld computers or Personal Digital Assistants
(PDAs) and Global Positioning Systems (GPS) present
innovative approaches that may simplify data capture
and enhance the quality of household and individual
identification data, and several studies have demonstrated
their usefulness for data capture, even in rural African
settings with limited electricity supply and harsh environ-
mental conditions (3438). Nevertheless, error is unlikely
to ever be completely eliminated from the data that we
have, therefore drawing correct quantitative conclusions
that can form the basis for public health intervention
necessitates that the effects of measurement error in the
data that we have are appreciated and accounted for (31).
Recent work suggests that high levels of purely random
errors may not be hugely detrimental to the utility of
population surveillance data based on large samples (39).
The expense and practical difficulty of detecting and
correcting random errors must be considered in relation
to the benefits of such efforts. Efforts will have a
diminishing return as the 100% accurate dataset is
approached, and so further consideration should be given
to redirecting the costs of such efforts towards increasing
the size or geographic spread of surveillance operations in
order to increase representativity, or indeed towards
analysing the data and disseminating findings.
Causes of death
Simply counting the number of deaths is not enough to
develop an understanding of population-level disease
profiles and important health transitions. Therefore,
cause-specific mortality measurement is vital and, for
the time being at least, verbal autopsy (VA) methods are
the only feasible way of obtaining such data for the
majority of the world’s population. VA methods gather
information from a close caregiver about the signs and
symptoms of the deceased’s terminal illness, as well as
lifestyle behaviours and other characteristics. This in-
formation is then used to derive probable causes of death,
most commonly through independent review of the data
by local physicians who try to reach consensus on a single
cause (40). Longstanding concerns over inter-observer
agreement and lack of standardisation of physician
review methods preclude meaningful comparisons of
cause-specific mortality between regions and over time,
where physicians and their methods of interpreting
evidence may differ (41). This lack of standardisation
has been tackled with efforts culminating in the develop-
ment of various algorithmic approaches based on the
concept of distilling the process of physician review into
standardised rules (42). Diagnostic algorithm-based
cause-of-death determination may be less accurate than
physician review, but has the advantage of being trans-
parent and repeatable. Nevertheless, algorithmic proce-
dures make it impossible to consider parallel possibilities
of causes of death along the lines of classic clinical
differential diagnoses, and their consistency depends on
$Demographic and Health Surveys are large, complex cross-
sectional surveys that measure demographic and health parameters
on a nationally representative cluster sample of households
performed at approximately five-year intervals, with each round
drawing a new cross-section sample.
%INDEPTH is an international organisation for the demographic
evaluation of populations and their health in developing countries.
It is a not-for-profit organisation that currently consists of around
35 health and demographic surveillance system (HDSS) sites in 18
countries in Africa, Asia, Central America and Oceania.
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the consistency of diagnostic criteria. Most HDSSs do
not currently employ diagnostic criteria for deriving
causes of death.
Limitations of physician review and traditional algo-
rithmic approaches have led to the development of more
innovative approaches to cause-of-death determination
based on VAs. Application of Bayes’ theorem for VA
interpretation has been developed and evaluated using
VA data from Vietnam, Ethiopia and Burkina Faso
(4345). Known as InterVA (for all age mortality) and
InterVA-M (for deaths in reproductive-aged women), the
approach derives up to three probable causes of death
from VA data and has been shown to produce compar-
able VA-derived cause-specific mortality fractions
(CSMFs) to physician review with the advantage of being
completely reliable  the same set of indicators, signs and
symptoms will always lead to the same probable cause of
death (4347). An alternative method developed by King
and Lu (48), directly estimates CSMFs without individual
cause-of-death attribution. Their method resolves the
problem of generalising VA analysis to the population
based on test properties quantified in health facility
validation studies. Combining King and Lu’s approach
with the InterVA method, Murray et al. (42) propose and
have attempted to validate a new approach called the
Symptom Pattern method. Such developments are wel-
come attempts to overcome limitations of current VA
methods and the fact that these innovative methods are
addressing differing data needs should be emphasised 
they do not offer a ‘one-size-fits-all’ solution.
Failure to emphasise the differing data needs that VA
methods are attempting to address can result in a narrow
assumption that VA is a direct surrogate for Western-style
cause-of-death determination. Rather than targeting
specific gaps in the understanding of mortality in less-
developed countries and considering whether the method
is now more or less fit for purpose, therefore, VA
developments tend to be discussed in terms of whether
they meet medical ideals. This reinforces illusions of a
‘one-size-fits-all’ solution to long-standing information
gaps, and limiting VAs to a medical model undermines
their full potential as epidemiological tools, which can be
adapted to any specific point along this chain of
economic, social, operational, biomedical and physical
events leading to death. VA may be designed to address
specific public health or mortality questions in a way that
Western, medical-based models cannot. Explicit targeting
of a specific point along the chain of events leading to
death is useful in terms of data collection and analysis
and may allow more useful discussions of new methods in
terms of adequacy for purpose rather than absolute
validity in relation to dubious gold standards (40, 49).
Such conceptual developments, however, will need to
overcome a default assumption of general medical
audiences that cause-of-death determination is solely for
the purposes of individual-level cause-of-death certifica-
tion. Filling gaps in population-level information is
arguably more important for health planning and mon-
itoring purposes than filling gaps in individual-level data.
Nevertheless, the largely individually derived and clini-
cally oriented International Classification of Disease
(ICD) coding, remains the mandatory level of coding
for international reporting to the WHO mortality data-
base (50). The purpose of such standardised disease
reporting rules is to ensure comparability, however the
assumption that individual deaths will be coded consis-
tently and reliably between regions and over time and can
be aggregated to identify population-level disease burdens
in different regions is flawed. The use of an individual-
focussed approach to address a population-level need
seems inappropriate. While individually VA-determined
causes may be methodologically easier to compare with
individually certified causes of death from other settings,
it does not necessarily imply a need for certainty at the
individual level. Rather, it emphasises the need for reliable
methods of interpreting CSMFs for known populations.
Furthermore, determining multiple, rather than single
causes of death for any particular case is more likely to
accurately reflect the interaction of different diseases that
lead to death and give a more complete representation of
broad, population-level cause categories for which the
public health response implications are essentially similar.
This may be less precise in terms of ICD coding, but
could be more suitable for guiding public health prior-
itisation on a more local level (8).
Users and uses: making deaths count
That the value of data lies in their use and not in their
collection does not always seem to be appreciated by
surveillance systems, often burdened with tight budgets
that hinder rapid local analyses (6, 51). A major challenge
facing population surveillance activities in general, and
HDSSs in particular, is the accumulation of unanalysed
data. All too often the period from data capture in the
field to analysis, publication and use for informing public
health action is very long. Even when data are processed
efficiently, they are rarely made widely available or
communicated effectively enough to have an immediate
effect on the lives of the surveillance population.
It is debatable whether sentinel surveillance and HDSS
operations in developing countries are directly respon-
sible for practical public health action, but to justify the
risks and intrusion of surveillance, the collected informa-
tion must have a demonstrated utility. Within the context
of humanitarian disasters, for example, important fluc-
tuations in surveillance population mortality should be
detectable and trigger action (29). Ill-defined responsi-
bilities, complex operational procedures and long time
lags between data capture and analysis are unacceptable
excuses for not using the data generated from population
Dying to count: mortality surveillance in resource-poor settings
5
(page number not for citation purpose)
surveillance activities for the timely detection of entirely
preventable morbidity and loss of life in the surveillance
population. While the standardisation, quality control
and validation of surveillance methods is important,
efforts are also needed to stimulate the debate and
development of simple procedures for using data and
clearly defined surveillance responsibilities. That popula-
tion surveillance activities in developing countries
typically operate in cooperation with local health autho-
rities, universities and local and foreign government
ministries means that key actors in health, development
and relief are likely to be receptive to efforts to enhance
communication with population surveillance organisa-
tions. In combination with data that may be collected by
other parties, such as environmental and meteorological
data, mortality information could enhance understanding
of environmental and population inter-relationships and
provide a more complete incentive for public health
action. That the data must be used to justify the effort
and intrusion on individual privacy is one principle that
fits all surveillance activities.
Reconciling ‘want’, ‘need’ and ‘have’
Establishment of registration systems for entire popula-
tions is unlikely to occur in the short to medium term; the
data we want will remain unobtainable. In the meantime,
sample-based and sentinel population and mortality
surveillance can yield sufficiently reliable and relevant
information for programme action, and are well within
the means of many developing countries. Indeed, such
systems represent the only useful alternative to establish
the evidence base for health policy and programme
delivery for the foreseeable future in much of the devel-
oping world. That the data we have may not be exactly the
data we want does not make evidence-based decision
making impossible  the data and evidence that we do
have should be used while efforts continue to be made to
improve the evidence base (52).
Understanding the potential advantages and limita-
tions of methods in particular contexts is important for
informing appropriate population survey design within
the boundaries of financial and logistical constraints.
However, as this paper repeatedly emphasises, there is no
single methodology that can fully satisfy all data needs.
Methodological decisions about surveillance should
therefore be a synthesis of all available and relevant
knowledge relating to clearly defined concepts of why
data are being collected, how they can be used and when
they are of good enough quality. A number of mathema-
tical principles have been developed to demarcate what
is ‘significant’ statistically, but no comparable principles
have been established to indicate what is significant
operationally in relation to public health action. Ulti-
mately, explicit discussion of such issues internationally as
well as with surveillance communities is not only vital to
improving the state of knowledge on the world’s health,
but also to maintaining public trust in, and understanding
of, health and demographic surveillance efforts. This, in
turn, may be a significant step towards more widespread,
routine, vital-event surveillance and the crucial goal of not
just counting deaths, but also making all deaths count.
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